Skip to main content

Want a detailed portfolio tracker?

Vericel (VCEL) P/E (2010 - 2026)

Vericel (VCEL) P/E from Jun 30, 2010 to Jul 21, 2026. The TTM Vericel (VCEL) P/E is 108.57. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Vericel (VCEL)

YearP/EChange
2026108.57-2.13%
2025110.93-58.48%
2024267.18-260.98%
2023-165.97+141.47%
2022-68.73-71.82%
2021-243.93-146.73%
2020522.02-772.65%
2019-77.61-0.39%
2018-77.91+933.94%
2017-7.54+92.93%
2016-3.91+4.00%
2015-3.76+148.42%
2014-1.51+167.34%
2013-0.57-97.80%
2012-25.70-30.77%
2011-37.12-28.91%
2010-52.21N/A

Comparison Vericel (VCEL) P/E with competitors

Vericel (VCEL) P/E is 108.57.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-99.93%
FGENFibroGen Inc0.24-99.78%
CHRSCoherus Biosciences Inc0.85-99.22%
FBIOFortress Biotech Inc0.95-99.13%
ORMPOramed Pharmaceuticals Inc1.50-98.62%
AGENAgenus Inc3.01-97.23%
INVAInnoviva Inc3.15-97.09%
VXRTVaxart Inc3.55-96.73%
CRMDCorMedix Inc3.63-96.66%
CVACCureVac N.V.4.45-95.91%
GLPGGalapagos NV4.86-95.52%
SRPTSarepta Therapeutics Inc4.88-95.50%
ABEOAbeona Therapeutics Inc5.39-95.04%
ABUSArbutus Biopharma Corp5.60-94.85%
ZVRAZevra Therapeutics Inc5.89-94.58%
SPROSpero Therapeutics Inc6.23-94.26%
CGENCompugen Ltd6.31-94.18%
RIGLRigel Pharmaceuticals6.87-93.67%
SLXNSilexion Therapeutics Corp7.30-93.28%
OMEROmeros Corporation9.26-91.47%
AUPHAurinia Pharmaceuticals Inc9.58-91.17%
PLXProtalix BioTherapeutics Inc10.89-89.97%
ACADAcadia Pharmaceuticals Inc11.73-89.20%
TBPHTheravance Biopharma Inc12.26-88.71%
ADMAAdma Biologics Inc12.42-88.56%
HRMYHarmony Biosciences Holdings Inc13.82-87.27%
SABSSAB Biotherapeutics Inc14.14-86.98%
NAGENiagen Bioscience Inc14.82-86.35%
INCYIncyte Corp15.82-85.43%
REGNRegeneron Pharmaceuticals Inc15.86-85.39%
PBYIPuma Biotechnology Inc17.32-84.05%
CPRXCatalyst Pharmaceuticals Inc17.44-83.94%
EXELExelixis Inc17.54-83.85%
TGTXTG Therapeutics Inc18.97-82.53%
MDXGMimedx Group Inc20.55-81.07%
XOMAXOMA Royalty Corp22.87-78.93%
ARGXArgen X SE24.30-77.62%
CTMXCytomX Therapeutics Inc24.82-77.14%
XOMAOXOMA Royalty Corp25.34-76.66%
HALOHalozyme Therapeutics Inc25.62-76.40%
XOMAPXOMA Royalty Corp25.67-76.36%
VRTXVertex Pharmaceuticals Inc27.99-74.21%
RPRXRoyalty Pharma plc - Class A28.69-73.58%
SLNOSoleno Therapeutics Inc29.02-73.27%
ASNDAscendis Pharma A/S30.09-72.29%
LGNDLigand Pharmaceuticals Inc - Class B37.91-65.08%
APLSApellis Pharmaceuticals Inc39.02-64.06%
BMRNBiomarin Pharmaceutical Inc42.21-61.12%
KRYSKrystal Biotech Inc45.34-58.23%
ONCBeiGene Ltd69.54-35.95%
PHARPharming Group N.V.75.03-30.89%
TECHBio-Techne Corp101.96-6.09%
ALNYAlnylam Pharmaceuticals Inc117.96+8.66%
GMABGenmab140.29+29.22%
TLXTelix Pharmaceuticals Ltd162.15+49.36%
CORTCorcept Therapeutics Inc212.86+96.06%